Why is Jagsonpal Pharma falling/rising?

As of 17-Sep, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 243.50, reflecting a decrease of Rs 4.9 or 1.97%. The stock has underperformed its sector by 2.01% today and has been on a downward trend for the last two days, with a total decline of 2.21%. Additionally, the stock touched an intraday low of Rs 242.4, indicating a lack of buying interest as the weighted average price suggests more volume was traded closer to this low. Despite a strong long-term performance with a 48.33% return over the past year and a remarkable 1370.41% increase over five years, the recent drop is compounded by a significant decrease in delivery volume, which fell by 43.02% against the five-day average.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with a 1-week return of -0.61% compared to the Sensex's gain of 1.56%. This underperformance in the short term contrasts with the company's healthy long-term growth indicators, such as a low debt-to-equity ratio and consistent positive results over the last five quarters. While the company has demonstrated strong operational growth, the recent decline in stock price may reflect market sentiment and reduced investor participation, which could be impacting its current trading dynamics.